BRIEF — Insitro Announces a Strategic Collaboration with AstraZeneca for AI — enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies
Oct 15 (Reuters) — AstraZeneca PLC: Insitro Announces A Strategic Collaboration With Astrazeneca For Ai-enabled Discovery Of Novel Therapeutics For Mash And Cardiomyopathies Insitro: Under Terms, Co To Receive $40 Million Upfront, Eligible For Up To About $1.46 Billion In Potential Discovery, Development, & Commercial